Insecticide resistance status of the Anopheles funestus population in Central African Republic: A challenge in the war

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Sangba, Marina Lidwine Olé ^a,b   Deketramete, Tanguy ^a,c   Wango, Solange Patricia ^c   Kazanji, Mirdad ^a   Akogbeto, Martin ^b,d   Ndiath, Mamadou Ousmane ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

^c Universite de Bangui   (Central African Republic)

^d CENTRE DE RECHERCHE ENTOMOLOGIQUE DE COTONOU CREC   (Benin)

Author keywords

Anopheles funestus; Bangui; Central African Republic; Insecticide resistance; kdr; Malaria

Indexed keywords

CHLORPHENOTANE; CYHALOTHRIN; CYTOCHROME P450 MONOOXYGENASE; DELTAMETHRIN; ESTERASE; GLUTATHIONE TRANSFERASE; MALATHION; OXYGENASE; PERMETHRIN; PIPERONYL BUTOXIDE; PYRETHROID; UNCLASSIFIED DRUG; CYTOCHROME P450; INSECTICIDE;

ADULT; ANOPHELES FUNESTUS; ARTICLE; CENTRAL AFRICAN REPUBLIC; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; INSECTICIDE RESISTANCE; KNOCKDOWN TIME; MORTALITY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PROTEIN FUNCTION; ANIMAL; ANOPHELES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANOPHELES; CENTRAL AFRICAN REPUBLIC; CYTOCHROME P-450 ENZYME SYSTEM; ESTERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE TRANSFERASE; INSECTICIDE RESISTANCE; INSECTICIDES;

EID: 84971628912     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1510-9     Document Type: Article

References (42)

1. WHO. World Malaria Report 2014. Geneva: World Health Organization; 2014. http://www.who.int/malaria/publications/world-malaria-report-2014/wmr-2014-no-profiles.pdf.
2. MSF. Rapport Médecins Sans Frontières 2015. République Centrafricaine. 2015. http://www.msf.fr/actualite/dossiers/republique-centrafricaine-crise-silencieuse.
3. MSF. Rapport Médecins Sans Frontières. Une Crise silencieuse République Centrafricaine. 2011. http://www.msf.fr/sites/www.msf.fr/files/ddp-rca-fr-low-res-1.pdf.
4. Manirakiza A, Njuimo SP, Le Faou A, Malvy D, Millet P. Availability of antimalarial drugs and evaluation of the attitude and practices for the treatment of uncomplicated malaria in Bangui, Central African Republic. East Afr J Public Health. 2009;6(3):292-5.
5. Manirakiza A, Serdouma E, Heredeibona LS, Djalle D, Madji N, Moyen M, Soula G, Le Faou A, Delmont J. Rational case management of malaria with a rapid diagnostic test, Paracheck Pf(R), in antenatal health care in Bangui, Central African Republic. BMC Public Health. 2012;12:482.
6. WHO. Insecticide-treatedmosquito nets: a WHO position statement. Global malaria programme. Geneva: World Health Organization; 2007. http://www.who.int/malaria/world-malaria-report-2011/9789241564403-eng.pdf.
7. Greenwood BM. Control to elimination: implications for malaria research. Trends Parasitol. 2008;24(10):449-54.
8. WHO. Pesticides and their applications for the control of vectors and pests of public health importance. WHO Geneva, WHO/CDS/NTD/WHOPES/GCDPP; 2006. http://apps.who.int/iris/bitstream/10665/69795/10661/WHO-CDS-NTD-WHOPES-GCDPP-12006.10661-eng.pdf.
9. Curtis CF. Insecticide treated mosquito nets. Trop Doct. 1998;28(1):63.
10. Greenwood B, Koram K. Malaria control in Africa: progress but still much to do. Lancet. 2014;383(9930):1703-4.
11. Trape JF, Tall A, Diagne N, Ndiath O, Ly AB, Faye J, Dieye-Ba F, Roucher C, Bouganali C, Badiane A, et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis. 2011;11(12):925-32.
12. PMI. President's Malaria Initiative Country Insecticide Susceptibility Summaries. 2015.
13. Ndiath MO, Sougoufara S, Gaye A, Mazenot C, Konate L, Faye O, Sokhna C, Trape JF. Resistance to DDT and pyrethroids and increased kdr mutation frequency in An. gambiae after the implementation of permethrin-treated nets in Senegal. PLoS One. 2012;7(2):e31943.
14. Corbel V, Akogbeto M, Damien GB, Djenontin A, Chandre F, Rogier C, Moiroux N, Chabi J, Banganna B, Padonou GG, et al. Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis. 2012;12(8):617-26.
15. Ngoagouni C, Kamgang B, Manirakiza A, Nangouma A, Paupy C, Nakoune E, Kazanji M. Entomological profile of yellow fever epidemics in the Central African Republic, 2006-2010. Parasit Vectors. 2012;5:175.
16. Fontenille D, Simard F. Unravelling complexities in human malaria transmission dynamics in Africa through a comprehensive knowledge of vector populations. Comp Immunol Microbiol Infect Dis. 2004;27(5):357-75.
17. Cuamba N, Morgan JC, Irving H, Steven A, Wondji CS. High level of pyrethroid resistance in an Anopheles funestus population of the Chokwe District in Mozambique. PLoS One. 2010;5(6):e11010.
18. Djouaka R, Irving H, Tukur Z, Wondji CS. Exploring mechanisms of multiple insecticide resistance in a population of the malaria vector Anopheles funestus in Benin. PLoS One. 2011;6(11):e27760.
19. Mulamba C, Riveron JM, Ibrahim SS, Irving H, Barnes KG, Mukwaya LG, Birungi J, Wondji CS. Widespread pyrethroid and DDT resistance in the major malaria vector Anopheles funestus in East Africa is driven by metabolic resistance mechanisms. PLoS One. 2014;9(10):e110058.
20. Okoye PN, Brooke BD, Koekemoer LL, Hunt RH, Coetzee M. Characterisation of DDT, pyrethroid and carbamate resistance in Anopheles funestus from Obuasi, Ghana. Trans R Soc Trop Med Hyg. 2008;102(6):591-8.
21. Ranson H, N'Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol. 2011;27(2):91-8.
22. IPB. Annual Institut Pasteur Bangui Report. Bangui: Institut Pasteur of Bangui; 2013. p. 62. http://www.pasteur.fr/sites/www.pasteur.fr/files/rapport-activites-2013-ip-bangui.pdf.
23. Gillies MT, De Meillon B. The Anophelinae of Africa South of the Sahara (Ethiopian zoogeographical region). Johannesburg: Publications of the South Africa Institute for Medical Research; 1968. p. 343.
24. Cohuet A, Simard F, Toto JC, Kengne P, Coetzee M, Fontenille D. Species identification within the Anopheles funestus group of malaria vectors in Cameroon and evidence for a new species. Am J Trop Med Hyg. 2003;69(2):200-5.
25. WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes WHO/CDS/CPC/MAL/D. Geneva: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/80139/10661/9789241505154-eng.pdf.
26. Brogdon WG, McAllister JC, Vulule J. Heme peroxidase activity measured in single mosquitoes identifies individuals expressing an elevated oxidase for insecticide resistance. J Am Mosq Control Assoc. 1997;13(3):233-7.
27. Hemingway J, Brogdon WG. Techniques to Detect Insecticide Resistance Mechanisms (Field and Laboratory Manual). In: Document WHO/CDS/CPC/MAL/986. Geneva: World Health Organ; 1998.
28. Morgan JC, Irving H, Okedi LM, Steven A, Wondji CS. Pyrethroid resistance in an Anopheles funestus population from Uganda. PLoS One. 2010;5(7):e11872.
29. Brooke BD, Kloke G, Hunt RH, Koekemoer LL, Temu EA, Taylor ME, Small G, Hemingway J, Coetzee M. Bioassay and biochemical analyses of insecticide resistance in southern African Anopheles funestus (Diptera: Culicidae). Bull Entomol Res. 2001;91(4):265-72.
30. Diabate A, Baldet T, Chandre F, Guiguemde RT, Brengues C, Guillet P, Hemingway J, Hougard JM. First report of the kdr mutation in Anopheles gambiae M form from Burkina Faso, west Africa. Parassitologia. 2002;44(3-4):157-8.
31. Chandre F, Darrier F, Manga L, Akogbeto M, Faye O, Mouchet J, Guillet P. Status of pyrethroid resistance in Anopheles gambiae sensu lato. Bull World Health Organ. 1999;77(3):230-4.
32. Czeher C, Labbo R, Arzika I, Duchemin JB. Evidence of increasing Leu-Phe knockdown resistance mutation in Anopheles gambiae from Niger following a nationwide long-lasting insecticide-treated nets implementation. Malar J. 2008;7:189.
33. Diabate A, Baldet T, Chandre F, Akoobeto M, Guiguemde TR, Darriet F, Brengues C, Guillet P, Hemingway J, Small GJ, et al. The role of agricultural use of insecticides in resistance to pyrethroids in Anopheles gambiae s.l. in Burkina Faso. Am J Trop Med Hyg. 2002;67(6):617-22.
34. Sokhna C, Ndiath MO, Rogier C. The changes in mosquito vector behaviour and the emerging resistance to insecticides will challenge the decline of malaria. Clin Microbiol Infect. 2013;19(10):902-7.
35. Witzig C, Parry M, Morgan JC, Irving H, Steven A, Cuamba N, Kerah-Hinzoumbe C, Ranson H, Wondji CS. Genetic mapping identifies a major locus spanning P450 clusters associated with pyrethroid resistance in kdr-free Anopheles arabiensis from Chad. Heredity (Edinb). 2013;110(4):389-97.
36. Riveron JM, Irving H, Ndula M, Barnes KG, Ibrahim SS, Paine MJ, Wondji CS. Directionally selected cytochrome P450 alleles are driving the spread of pyrethroid resistance in the major malaria vector Anopheles funestus. Proc Natl Acad Sci U S A. 2013;110(1):252-7.
37. Feachem RG, Sabot OJ. Global malaria control in the 21st century: a historic but fleeting opportunity. JAMA. 2007;297(20):2281-4.
38. Fonseca-Gonzalez I, Quinones ML, McAllister J, Brogdon WG. Mixed-function oxidases and esterases associated with cross-resistance between DDT and lambda-cyhalothrin in Anopheles darlingi Root 1926 populations from Colombia. Mem Inst Oswaldo Cruz. 2009;104(1):18-26.
39. Casimiro S, Coleman M, Mohloai P, Hemingway J, Sharp B. Insecticide resistance in Anopheles funestus (Diptera: Culicidae) from Mozambique. J Med Entomol. 2006;43(2):267-75.
40. RBM. Technical support network for insecticide-treated netting materials: scaling-up insecticide-treated netting programmes in Africa. In: Roll Back Malaria, editor. A strategic framework for coordinated national action, 14. Geneva: WHO; 2002. p. 1-5.
41. Zaim M, Aitio A, Nakashima N. Safety of pyrethroid-treated mosquito nets. Med Vet Entomol. 2000;14(1):1-5.
42. Feachem R, Sabot O. A new global malaria eradication strategy. Lancet. 2008;371(9624):1633-5.